Concepedia

Mark T. Liddament

MT

Statistics

Publications

6

Citations

782

H-Index

6

Active since

2004

Affiliations

University of Minnesota(Current)

CSL (Australia)

Mark T. Liddament is an author at University of Minnesota specializing in molecular virology, antibody characterization, and life sciences.

ORCID

Publications per year

2004–2022

6

Publications

6

APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo

Mark T. Liddament, William L. Brown, April J. Schumacher et al. · Current Biology · 2004 · 439 citations · Full text

, , +7

The Retroviral Hypermutation Specificity of APOBEC3F and APOBEC3G Is Governed by the C-terminal DNA Cytosine Deaminase Domain

Guylaine Haché, Mark T. Liddament, Reuben S. Harris · Journal of Biological Chemistry · 2005 · 191 citations · Full text

, , +9

Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain

Adam K. Wheatley, Phillip Pymm, Robyn Esterbauer et al. · Cell Reports · 2021 · 80 citations · Full text

, , +17

Higher Binding Affinity and <i>In Vitro</i> Potency of Reslizumab for Interleukin-5 Compared With Mepolizumab

Mark T. Liddament, Jean Husten, Tanya Estephan et al. · Allergy Asthma and Immunology Research · 2019 · 25 citations · Full text

, , +14

Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor Antibodies

Nadya Panagides, Lucía F. Zacchi, Mitchell J. de Souza et al. · International Journal of Molecular Sciences · 2022 · 24 citations · Full text

, , +16

1–5 of 6